Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China · Delayed Price · Currency is CNY

2.130

-0.120 (-5.33%)

Oct 23, 2026, 3:00 PM CST

Market Cap	6.78B -25.5%
Revenue (ttm)	1.44B -16.4%
Net Income	-431.80M
EPS	-0.14
Shares Out	3.18B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,569,008
Open	2.200
Previous Close	2.250
Day's Range	2.040 - 2.200
52-Week Range	1.710 - 3.100
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and othe... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1993

Employees 2,843

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600252

Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -16.92% compared to the previous year's 2.10 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements